Published in J Bone Miner Res on April 01, 1988
The effect of age, weight, and lifestyle factors on calcaneal quantitative ultrasound: the ESOPO study. Osteoporos Int (2003) 2.22
Determinants of bone density in normal women: risk factors for future osteoporosis? BMJ (1989) 2.07
Linkage of a gene causing high bone mass to human chromosome 11 (11q12-13) Am J Hum Genet (1997) 1.75
A practical guide to preventing osteoporosis. West J Med (1988) 1.40
Milk and bones. BMJ (1994) 1.27
Atherosclerosis and osteoporosis: age-dependent degenerative processes or related entities? Osteoporos Int (2008) 1.06
Factor analysis of biochemical markers associated with bone mineral density in adults. J Phys Ther Sci (2014) 1.05
Lifetime milk consumption and bone mineral density in older women. Am J Public Health (1994) 1.02
Osteoporosis--an epidemiological perspective: a review. J R Soc Med (1989) 0.98
Development and validation of the osteoporosis prescreening risk assessment (OPERA) tool to facilitate identification of women likely to have low bone density. Clin Rheumatol (2004) 0.93
Effect of green tea and Tai Chi on bone health in postmenopausal osteopenic women: a 6-month randomized placebo-controlled trial. Osteoporos Int (2011) 0.92
Effects of physical activity, dietary calcium intake and selected lifestyle factors on bone density in young women. CMAJ (1990) 0.90
Green tea polyphenols and Tai Chi for bone health: designing a placebo-controlled randomized trial. BMC Musculoskelet Disord (2009) 0.85
Dietary calcium, sex hormones, and bone mineral density in men. BMJ (1990) 0.83
The peak bone mass concept. Clin Rheumatol (1989) 0.80
Racial difference in the correlates of bone mineral content/density and age at peak among reproductive-aged women. Osteoporos Int (2009) 0.78
Response of parathyroid hormone to exercise and bone mineral density in adolescent female athletes. Environ Health Prev Med (1998) 0.78
Role of calcium and vitamin D in the prevention and the treatment of postmenopausal osteoporosis: an overview. Clin Rheumatol (1995) 0.77
Calcium requirements for optimal skeletal health in women. Calcif Tissue Int (1991) 0.77
Understanding osteoporosis. West J Med (1991) 0.76
Calcium revisited, part III: effect of dietary calcium on BMD and fracture risk. Bonekey Rep (2015) 0.75
Safety and efficacy of tocotrienol supplementation for bone health in postmenopausal women: protocol for a dose-response double-blinded placebo-controlled randomised trial. BMJ Open (2016) 0.75
Practice guidelines for the treatment of osteoporosis. Calcif Tissue Int (1996) 0.75
The genome of the social amoeba Dictyostelium discoideum. Nature (2005) 9.18
Updated data on proximal femur bone mineral levels of US adults. Osteoporos Int (1998) 7.14
Clinician's Guide to Prevention and Treatment of Osteoporosis. Osteoporos Int (2014) 5.17
The effects of frequent nocturnal home hemodialysis: the Frequent Hemodialysis Network Nocturnal Trial. Kidney Int (2011) 4.27
Long-term prevention of postmenopausal osteoporosis by oestrogen. Evidence for an increased bone mass after delayed onset of oestrogen treatment. Lancet (1976) 4.24
Insulin-like growth factor-I in men with idiopathic osteoporosis. J Clin Endocrinol Metab (1997) 3.00
Skeletal disease in primary hyperparathyroidism. J Bone Miner Res (1989) 3.00
An assessment tool for predicting fracture risk in postmenopausal women. Osteoporos Int (2001) 2.94
Interim report and recommendations of the World Health Organization Task-Force for Osteoporosis. Osteoporos Int (1999) 2.70
Effects of daily treatment with parathyroid hormone on bone microarchitecture and turnover in patients with osteoporosis: a paired biopsy study. J Bone Miner Res (2001) 2.65
Calcium potentiates the effect of estrogen and calcitonin on bone mass: review and analysis. Am J Clin Nutr (1998) 2.37
Effectiveness of bisphosphonates on nonvertebral and hip fractures in the first year of therapy: the risedronate and alendronate (REAL) cohort study. Osteoporos Int (2006) 2.34
Prevention of spinal osteoporosis in oophorectomised women. Lancet (1980) 2.34
Two types of astrocytes in cultures of developing rat white matter: differences in morphology, surface gangliosides, and growth characteristics. J Neurosci (1983) 2.18
Parathyroid hormone as a therapy for idiopathic osteoporosis in men: effects on bone mineral density and bone markers. J Clin Endocrinol Metab (2000) 2.14
Anabolic actions of parathyroid hormone on bone. Endocr Rev (1993) 2.13
Resistance to bone resorbing effects of PTH in black women. J Bone Miner Res (1997) 1.98
Fracture history and bone loss in patients with MS. Neurology (1998) 1.97
Pathogenesis of osteoporosis. Lancet (1993) 1.93
The Global Longitudinal Study of Osteoporosis in Women (GLOW): rationale and study design. Osteoporos Int (2009) 1.85
Importance of precision in bone density measurements. J Clin Densitom (2001) 1.82
The minimum effective dose of estrogen for prevention of postmenopausal bone loss. Obstet Gynecol (1984) 1.80
Oestrogen replacement therapy for prevention of osteoporosis after oophorectomy. Br Med J (1973) 1.79
The efficacy and tolerability of risedronate once a week for the treatment of postmenopausal osteoporosis. Calcif Tissue Int (2002) 1.61
Teriparatide effects on vertebral fractures and bone mineral density in men with osteoporosis: treatment and discontinuation of therapy. Osteoporos Int (2004) 1.57
High prevalence of vitamin D deficiency and reduced bone mass in multiple sclerosis. Neurology (1994) 1.54
On the mechanism of cancellous bone preservation in postmenopausal women with mild primary hyperparathyroidism. J Clin Endocrinol Metab (1999) 1.53
Progeston therapy for menstrually related aphthae. Int J Oral Surg (1978) 1.52
Assessment of trabecular and cortical architecture and mechanical competence of bone by high-resolution peripheral computed tomography: comparison with transiliac bone biopsy. Osteoporos Int (2009) 1.52
The histomorphometry of bone in primary hyperparathyroidism: preservation of cancellous bone structure. J Clin Endocrinol Metab (1990) 1.51
Comparative effects of oestrogen and a progestogen on bone loss in postmenopausal women. Clin Sci Mol Med (1978) 1.50
Exogenous calciferol (vitamin D) and vitamin D endocrine status among elderly nursing home residents in the New York City area. J Am Geriatr Soc (1993) 1.42
Constant mineralization density distribution in cancellous human bone. Bone (2003) 1.41
Therapeutic controversy: Estrogen replacement in menopause. J Clin Endocrinol Metab (1996) 1.41
The effects of vitamin D insufficiency in patients with primary hyperparathyroidism. Am J Med (1999) 1.40
Bone response to termination of oestrogen treatment. Lancet (1978) 1.38
The redistribution of body sodium in women on long-term oestrogen therapy. Clin Sci Mol Med (1974) 1.38
Prevention of bone mineral loss in postmenopausal women by norethisterone. Obstet Gynecol (1985) 1.37
Histomorphometric assessment of bone mass, structure, and remodeling: a comparison between healthy black and white premenopausal women. J Bone Miner Res (1997) 1.36
Parathyroid hormone added to established hormone therapy: effects on vertebral fracture and maintenance of bone mass after parathyroid hormone withdrawal. J Bone Miner Res (2001) 1.33
Odanacatib for the treatment of postmenopausal osteoporosis: development history and design and participant characteristics of LOFT, the Long-Term Odanacatib Fracture Trial. Osteoporos Int (2014) 1.29
Milk and bones. BMJ (1994) 1.27
The clinical diagnosis of osteoporosis: a position statement from the National Bone Health Alliance Working Group. Osteoporos Int (2014) 1.27
Elementary schoolteachers' understanding of diabetes. Diabetes Educ (1987) 1.27
Effect of pH on bone resorption by rat osteoclasts in vitro. Endocrinology (1986) 1.26
Prospective double-blind trial of synthetic steroid (Org OD 14) for preventing postmenopausal osteoporosis. Br Med J (1980) 1.24
Maintenance of cancellous bone connectivity in primary hyperparathyroidism: trabecular strut analysis. J Bone Miner Res (1992) 1.23
Prevention of osteoporosis. Clin Orthop Relat Res (1987) 1.22
Mean wall thickness and formation periods of trabecular bone packets in corticosteroid-induced osteoporosis. Calcif Tissue Int (1983) 1.21
Serum vitamin D2 and vitamin D3 metabolite concentrations and absorption of vitamin D2 in elderly subjects. J Clin Endocrinol Metab (1986) 1.18
Osteoporosis after oophorectomy for non-malignant disease in premenopausal women. Br Med J (1973) 1.17
Long-term effects of raloxifene on bone mineral density, bone turnover, and serum lipid levels in early postmenopausal women: three-year data from 2 double-blind, randomized, placebo-controlled trials. Arch Intern Med (2000) 1.17
"Epileptic" brain damage is replicated qualitatively in the rat hippocampus by central injection of glutamate or aspartate but not by GABA or acetylcholine. Brain Res Bull (1985) 1.16
Effect of Na, metabolic inhibitors and ATP on Ca movements in L cells. J Physiol (1971) 1.16
Effects of tamoxifen on spinal bone density in women with breast cancer. J Natl Cancer Inst (1989) 1.15
Localization of rat cathepsin K in osteoclasts and resorption pits: inhibition of bone resorption and cathepsin K-activity by peptidyl vinyl sulfones. Biol Chem (1999) 1.14
The anabolic effects of parathyroid hormone. Osteoporos Int (2002) 1.13
A comparative study of disaggregated chick and rat osteoclasts in vitro: effects of calcitonin and prostaglandins. Endocrinology (1987) 1.12
Estrogen protection against bone resorbing effects of parathyroid hormone infusion. Assessment by use of biochemical markers. Ann Intern Med (1993) 1.11
Temporal expression of the anabolic action of PTH in cancellous bone of ovariectomized rats. J Bone Miner Res (1996) 1.09
Zinc is a potent inhibitor of osteoclastic bone resorption in vitro. J Bone Miner Res (1995) 1.09
Reduced bone mass and fat-free mass in women with multiple sclerosis: effects of ambulatory status and glucocorticoid Use. Calcif Tissue Int (1997) 1.08
A comparison of two laser-based methods for determination of burn scar perfusion: laser Doppler versus laser speckle imaging. Burns (2005) 1.08
Fluoride and bone--quantity versus quality. N Engl J Med (1990) 1.08
Circulating osteogenic precursor cells in type 2 diabetes mellitus. J Clin Endocrinol Metab (2012) 1.08
Screening for hyperglycaemia in pregnancy: a rapid update for the National Screening Committee. Health Technol Assess (2010) 1.06
Immunocytochemical localization of the 1,25-dihydroxyvitamin D3 receptor in target cells. Endocrinology (1988) 1.06
Migration of axonal protein: absence of a protein concentration gradient and effect of inhibition of protein synthesis. Exp Brain Res (1967) 1.05
Continuous parathyroid hormone and estrogen administration increases vertebral cancellous bone volume and cortical width in the estrogen-deficient rat. J Bone Miner Res (2001) 1.05
Premenopausal women with idiopathic low-trauma fractures and/or low bone mineral density. Osteoporos Int (2011) 1.03
A new manual method for assessing two-dimensional cancellous bone structure: comparison between iliac crest and lumbar vertebra. J Bone Miner Res (1991) 1.03
Selective estrogen receptor modulators: clinical spectrum. Endocr Rev (1999) 1.03
The contribution of trabecular architecture to cancellous bone quality. J Bone Miner Res (2000) 1.02
Identifying the last supper: utility of the DNA barcode library for bloodmeal identification in ticks. Mol Ecol Resour (2012) 1.01
Estrogens, bone loss and preservation. Osteoporos Int (1990) 1.01
Bone-resorbing activity in the sera of patients with rheumatoid arthritis. Clin Sci Mol Med (1976) 1.00
Anabolic action of parathyroid hormone on cortical and cancellous bone differs between axial and appendicular skeletal sites in mice. Bone (2003) 1.00
Tumor-induced osteomalacia: clinical and basic studies. J Bone Miner Res (1997) 1.00
The systemic effect of intraarticular administration of corticosteroid on markers of bone formation and bone resorption in patients with rheumatoid arthritis. Arthritis Rheum (1996) 1.00
Is reactive gliosis a property of a distinct subpopulation of astrocytes? J Neurosci (1986) 0.99
Short-term continuous infusion of human parathyroid hormone 1-34 fragment is catabolic with decreased trabecular connectivity density accompanied by hypercalcemia in C57BL/J6 mice. J Endocrinol (2005) 0.98
Quantitation and localisation of aluminum in human cancellous bone in renal osteodystrophy. Scan Electron Microsc (1981) 0.97
Characterization and evaluation of asymptomatic primary hyperparathyroidism. J Bone Miner Res (1991) 0.97
Genetic and serotypic characterization of Sin Nombre-like viruses in Canadian Peromyscus maniculatus mice. Virus Res (2001) 0.97
Radiological determination of changes in bone mineral content. Radiography (1978) 0.96
The effect of endogenous oestrogen on plasma and urinary calcium and phosphate in oophorectomized women. Clin Endocrinol (Oxf) (1977) 0.96
Short-term changes in histomorphometric and biochemical turnover markers and bone mineral density in estrogen-and/or dietary calcium-deficient rats. Bone (1995) 0.96
Human osteoclast formation and activity in vitro: effects of alendronate. J Bone Miner Res (1998) 0.96
Temporal changes in cancellous bone structure of rats immediately after ovariectomy. Bone (1995) 0.96